Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Sears

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
JCI Insight|February 19, 2026
Sympathetic nerve-fibroblast crosstalk drives nerve injury, fibroblast activation, and matrix remodeling in pancreatic cancerAriana L Sattler, Parham Diba, Kevin Hawthorne, et al.
JCI Insight|January 14, 2025
Highly multiplexed imaging reveals prognostic immune and stromal spatial biomarkers in breast cancerJennifer R Eng, Elmar Bucher, Zhi Hu, et al.
STAR Protocols|March 6, 2025
Protocol to purify and culture human pancreatic cancer cells from patient-derived xenograftsJulien Tessier, Dmytro Grygoryev, Marilynn Chow-Castro, et al.
Cancer Research|July 12, 2022
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAILRussell Moser, James Annis, Olga Nikolova, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Pancreatic cancer-intrinsic HuR regulates the pro-tumorigenic properties of extracellular vesiclesJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Cell Reports|August 4, 2015
Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative ProliferationKevin Myant, Xi Qiao, Tuuli Halonen, et al.
Cancer Research Communications|August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic CancerJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Cancer Biology & Therapy|November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stressJennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Immunity|April 3, 2026
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironmentVivien I Maltez, Charu Arora, Kyle P Gribbin, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinomaYifei Guo, Jennifer M Finan, Alexandra Q Bartlett, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
JCI Insight|February 19, 2026
Sympathetic nerve-fibroblast crosstalk drives nerve injury, fibroblast activation, and matrix remodeling in pancreatic cancerAriana L Sattler, Parham Diba, Kevin Hawthorne, et al.
JCI Insight|January 14, 2025
Highly multiplexed imaging reveals prognostic immune and stromal spatial biomarkers in breast cancerJennifer R Eng, Elmar Bucher, Zhi Hu, et al.
STAR Protocols|March 6, 2025
Protocol to purify and culture human pancreatic cancer cells from patient-derived xenograftsJulien Tessier, Dmytro Grygoryev, Marilynn Chow-Castro, et al.
Cancer Research|July 12, 2022
Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAILRussell Moser, James Annis, Olga Nikolova, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Pancreatic cancer-intrinsic HuR regulates the pro-tumorigenic properties of extracellular vesiclesJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Cell Reports|August 4, 2015
Serine 62-Phosphorylated MYC Associates with Nuclear Lamins and Its Regulation by CIP2A Is Essential for Regenerative ProliferationKevin Myant, Xi Qiao, Tuuli Halonen, et al.
Cancer Research Communications|August 15, 2025
HuR-Regulated Extracellular Vesicles Promote Endothelial Cell Remodeling in Pancreatic CancerJennifer M Finan, Yifei Guo, Alexandra Q Bartlett, et al.
Cancer Biology & Therapy|November 8, 2024
The polymeric fluoropyrimidine CF10 overcomes limitations of 5-FU in pancreatic ductal adenocarcinoma cells through increased replication stressJennifer M Finan, Roberto Di Niro, Soon Young Park, et al.
Immunity|April 3, 2026
Agonistic anti-CD40 antibody treatment converts resident regulatory T cells into activated type 1 effectors within the tumor microenvironmentVivien I Maltez, Charu Arora, Kyle P Gribbin, et al.
Biorxiv : the Preprint Server for Biology|April 28, 2025
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinomaYifei Guo, Jennifer M Finan, Alexandra Q Bartlett, et al.
Pageof 20